New results from a study of a drug called Gazyva (obinutuzumab) showed that it significantly reduced disease activity in ...

As the government shutdown continues, many people are facing disruptions to their income and benefits. For people with lupus, ...

We were joined by various experts who shared their expert insights, practical tips and candid experiences to help others navigate sex, intimacy and self-confidence while living with lupus.

The Lupus Foundation of America (LFA) proudly presented eight abstracts and sessions during the 2025 American College of Rheumatology (ACR) Convergence with the goal of advancing science, improving ...

The Lupus Foundation of America (LFA) celebrated exceptional lupus researchers at the 20th Anniversary Evelyn V. Hess ...

Supporting lupus patients and advocates in Arizona.

The Lupus Foundation of America (LFA) and its funded researchers will unveil the latest advances in patient-centered research ...

The U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab), developed by Genentech, as a treatment for adults with lupus nephritis (LN), also known as lupus-related kidney disease ...